KRAS and non-small cell lung carcinoma: Our objective was to sequence KRAS and compare expression of NQO1 as well as a panel of five clinically relevant proteins in 108 non-small cell lung carcinoma (NSCLC), the most common form of LC, patients with and without KRAS mutations.